Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Biochemical Pharmacology

• Publication date

  2007-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BCP.2007.03.004PMID 17582384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cisplatin and Oxaliplatin, but Not Carboplatin and Nedaplatin, Are Substrates for Human Organic Cation Transporters (SLC22A1–3 and Multidrug and Toxin Extrusion Family)

  2006cited by this paper
• Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2.

  2006cited by this paper
• Molecular Cloning, Functional Characterization and Tissue Distribution of Rat H+/Organic Cation Antiporter MATE1

  2006cited by this paper
• Cellular processing of platinum anticancer drugs

  2005cited by this paper
• Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation.

  2005cited by this paper
• Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2.

  2005cited by this paper
• Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat.

  2005cited by this paper
• A human transporter protein that mediates the final excretion step for toxic organic cations.

  2005cited by this paper
• Pharmacological and Physiological Functions of the Polyspecific Organic Cation Transporters: OCT1, 2, and 3 (SLC22A1-3)

  2004cited by this paper
• Nephrotoxicity of platinum complexes is related to basolateral organic cation transport.

  2004cited by this paper
• Creatinine Transport by Basolateral Organic Cation Transporter hOCT2 in the Human Kidney

  2004cited by this paper
• Expression of Osteopontin in Cisplatin-Induced Tubular Injury

  2004cited by this paper
• Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance.

  2003cited by this paper
• Cisplatin and platinum drugs at the molecular level. (Review).

  2003cited by this paper
• Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3

  2002cited by this paper
• Cellular and molecular pharmacology of oxaliplatin.

  2002cited by this paper
• Distinct Characteristics of Organic Cation Transporters, OCT1 and OCT2, in the Basolateral Membrane of Renal Tubules

  2001cited by this paper
• Cellular and molecular aspects of drug transport in the kidney.

  2000cited by this paper
• Clinical pharmacokinetics of oxaliplatin: a critical review.

  2000cited by this paper
• Cisplatin-induced toxicity in LLC-PK1 kidney epithelial cells: role of basolateral membrane transport.

  1999cited by this paper
• Urine N-acetyl-beta-D-glucosaminidase--a marker of tubular damage?

  1999cited by this paper
• Cloning and Functional Characterization of a Potential-sensitive, Polyspecific Organic Cation Transporter (OCT3) Most Abundantly Expressed in Placenta*

  1998cited by this paper
• Kidney Injury Molecule-1 (KIM-1), a Putative Epithelial Cell Adhesion Molecule Containing a Novel Immunoglobulin Domain, Is Up-regulated in Renal Cells after Injury*

  1998cited by this paper
• Renal secretion of organic anions and cations.

  1996cited by this paper
• cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2.

  1996cited by this paper
• Drug excretion mediated by a new prototype of polyspecific transporter

  1994cited by this paper
• Mechanisms mediating renal secretion of organic anions and cations.

  1993cited by this paper
• Comparative insights into the mechanisms of renal organic anion and cation secretion.

  1991cited by this paper

• Role of solute carrier transporters in the biodistribution and toxicity of chemotherapeutic drugs.

  2026cites this paper
• Drug-Resistant Cholangiocarcinoma Cell Lines for Therapeutic Evaluation of Novel Drugs

  2025cites this paper
• Lansoprazole identified as a prophylactic agent for oxaliplatin-induced peripheral neuropathy using integrated in silico, in vitro, and in vivo analyses.

  2025cites this paper
• Protective Effect of Palonosetron against Cisplatin-Induced Cytotoxicity via Decreased Phosphorylation of p38.

  2025cites this paper
• Identification of dequalinium as a potent inhibitor of human organic cation transporter 2 by machine learning based QSAR model

  2025cites this paper
• Preoperatory FLOT Regimen for Gastroesophageal Cancer and Renal Function: A New Onco-Nephrological Perspective

  2025cites this paper
• Controlling nephron precursor differentiation to generate proximal-biased kidney organoids with emerging maturity

  2025cites this paper
• Organic cation transporters 2: Structure, regulation, functions, and clinical implications.

  2025cites this paper
• Predicting OCT2/MATEs‐Mediated Drug Interactions in Healthy Volunteers and Patients with Chronic Kidney Disease: Insights from Extended Clearance Concept, Endogenous Biomarkers, and In Vitro Inhibition Studies (Perspectives from the International Transporter Consortium)

  2025cites this paper
• Evaluation of Ototoxic Effects of Cisplatin in a Rat Model: A Dose–Response Study

  2025cites this paper
• Esomeprazole prevents oxaliplatin-induced peripheral neuropathy through inhibiting organic cation transporter 2 in mice.

  2025cites this paper
• An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management

  2024cites this paper
• Cisplatin Nephrotoxicity Is Critically Mediated by the Availability of BECLIN1

  2024cites this paper
• Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy

  2024cites this paper
• Evaluation of Cisplatin-Induced Acute Kidney Injury in Patients Coprescribed Serotonin Receptor Antagonists: A Retrospective Analysis

  2024cites this paper
• Susceptibility of mouse cochlear hair cells to cisplatin ototoxicity largely depends on sensory mechanoelectrical transduction channels both Ex Vivo and In Vivo.

  2024cites this paper
• An anti-neoplastic tale of metformin through its transport.

  2024cites this paper
• Interaction of the chemotherapeutic agent oxaliplatin and the tyrosine kinase inhibitor dasatinib with the organic cation transporter 2

  2024cites this paper
• The culmination of multidrug-resistant efflux pumps vs. meager antibiotic arsenal era: Urgent need for an improved new generation of EPIs

  2023cites this paper
• Genetic variation in organic cation transporters and considerations in drug development

  2023cites this paper
• Oxaliplatin and its derivatives – An overview

  2023cites this paper
• Biopsy-proven first dose of oxaliplatin-induced acute tubular necrosis leading to end-stage renal failure: a case report

  2023cites this paper
• Proton Pump Inhibitors Ameliorate Oxaliplatin-induced Peripheral Neuropathy: Retrospective Analysis of Two Real-world Clinical Databases

  2023cites this paper
• Genetics of diabetes-associated microvascular complications

  2023cites this paper
• Kidney Drug Transporters in Pharmacotherapy

  2023cites this paper
• Anticancer drug therapy for patients with renal dysfunction

  2023cites this paper
• Valproic acid treatment attenuates cisplatin‐induced kidney injury by suppressing proximal tubular cell damage

  2023cites this paper
• Drug-Induced Acute Kidney Injury

  2022cites this paper
• How platinum-induced nephrotoxicity occurs? Machine learning prediction in non-small cell lung cancer patients

  2022cites this paper
• Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development

  2022cites this paper
• Nanocarriers containing platinum compounds for combination chemotherapy

  2022cites this paper
• Membrane Carriers and Transporters in Kidney Physiology and Disease

  2021cites this paper
• Role of Renal Transporters in Drug–Drug Interactions and Nephrotoxicity

  2021cites this paper
• Severe AKI induced by Oxaliplatin: A case report

  2021cites this paper
• DNA methyltransferase inhibitors (DNMTis) as sensitizing agents to overcome chemoresistance

  2021cites this paper
• In Vitro and In Vivo Inhibition of MATE1 by Tyrosine Kinase Inhibitors

  2021cites this paper
• Comparisons of segment-specific toxicity of platinum-based agents and cadmium using S1, S2, and S3 cells derived from mouse kidney proximal tubules.

  2021cites this paper
• The structure of the Aquifex aeolicus MATE family multidrug resistance transporter and sequence comparisons suggest the existence of a new subfamily

  2021cites this paper
• In Vitro Nephrotoxicity Studies of Established and Experimental Platinum-Based Compounds

  2021cites this paper
• Suppressed Hepatic Production of Indoxyl Sulfate Attenuates Cisplatin-Induced Acute Kidney Injury in Sulfotransferase 1a1-Deficient Mice

  2021cites this paper
• Platinum accumulation in oxaliplatin‐induced peripheral neuropathy

  2021influential citation
• Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced Nephrotoxicity

  2021cites this paper
• Management of acute kidney injury in gastrointestinal tumor: An overview

  2021cites this paper
• Antioxidant effect of ascorbic acid against cisplatin-induced nephrotoxicity and P-glycoprotein expression in rats.

  2021cites this paper
• Population Pharmacokinetic Model-Based Evaluation of Intact Oxaliplatin in Rats with Acute Kidney Injury

  2021cites this paper
• Platinum-Induced Peripheral Neuropathy (PIPN): ROS-Related Mechanism, Therapeutic Agents, and Nanosystems

  2021cites this paper
• Cationic Compounds with SARS-CoV-2 Antiviral Activity and Their Interaction with Organic Cation Transporter/Multidrug and Toxin Extruder Secretory Transporters

  2021cites this paper
• A recombinant platform to characterize the role of transmembrane protein hTMEM205 in Pt(ii)-drug resistance and extrusion.

  2020cites this paper
• Rapid Regulation of Human Multidrug and Extrusion Transporters hMATE1 and hMATE2K

  2020cites this paper
• Role of SLC transporters in toxicity induced by anticancer drugs

  2020cites this paper
• Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?

  2020cites this paper
• Comparison of the nephroprotective effects of non-steroidal anti-inflammatory drugs on cisplatin-induced nephrotoxicity in vitro and in vivo.

  2020cites this paper
• Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells

  2020cites this paper
• The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents

  2020cites this paper
• Genetic and epigenetic modulation of drug resistance in cancer: Challenges and opportunities.

  2020cites this paper
• A pharmaceutical industry perspective on microphysiological kidney systems for evaluation of safety for new therapies.

  2020cites this paper
• Germacrone Reduces Cisplatin-Induced Toxicity of Renal Proximal Tubular Cells via Inhibition of Organic Cation Transporter.

  2020cites this paper
• Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics

  2020cites this paper
• PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2

  2020cites this paper
• Does exercise training attenuate cisplatin nephrotoxicity?

  2020cites this paper
• Predictive and translational models for renal drug safety evaluation

  2020cites this paper
• Canagliflozin reduces cisplatin uptake and activates Akt to protect against cisplatin-induced nephrotoxicity.

  2020cites this paper
• Organic Cation Transporters in Health and Disease

  2020cites this paper
• Role of transporters in drug disposition and drug-drug interactions

  2020cites this paper
• Transporter-Mediated Drug-Drug Interactions and Their Significance.

  2019cites this paper
• Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines

  2019cites this paper
• ABC Family Transporters.

  2019cites this paper
• A case of biopsy-proven oxaliplatin-induced acute tubulointerstitial nephritis with thrombocytopenia and anemia

  2019cites this paper
• SLC Family Transporters.

  2019cites this paper
• Structural biology of the multidrug and toxic compound extrusion superfamily transporters.

  2019cites this paper
• Identification of MRP2 as a targetable factor limiting oxaliplatin accumulation and response in gastrointestinal cancer

  2019cites this paper
• Toxicity Evaluation Using Animal and Cell Models

  2019cites this paper
• Food Safety & Mycotoxins

  2019cites this paper
• Establishment of renal proximal tubule cell lines derived from the kidney of p53 knockout mice

  2019cites this paper
• Cisplatin, rather than oxaliplatin, increases paracellular permeability of LLC-PK1 cells via activating protein kinase C.

  2019cites this paper
• The effect of diabetes mellitus on pharmacokinetics, pharmacodynamics and adverse drug reactions of anticancer drugs

  2019cites this paper
• Metallodrugs for therapy and imaging: investigation of their mechanism of action

  2018cites this paper
• Drug transporter expression profiling in a three-dimensional kidney proximal tubule in vitro nephrotoxicity model

  2018cites this paper
• Selective Inhibition on Organic Cation Transporters by Carvedilol Protects Mice from Cisplatin-Induced Nephrotoxicity

  2018cites this paper
• Structural Factors Affecting Binding of Platinum Anticancer Agents with Phospholipids: Influence of Charge and Phosphate Clamp Formation.

  2018cites this paper
• Renal Toxicology/Nephrotoxicity of Metals and Nanometallic Particles: Arsenic, Bismuth, Cadmium, Chromium, Indium, Lead, Platinum, Uranium, and Metallic Mixtures

  2018cites this paper
• Special Section – New Models in Drug Metabolism and Transport — Minireview Emerging Kidney Models to Investigate Metabolism , Transport , and Toxicity of Drugs and Xenobiotics

  2018cites this paper
• Advances in predictive in vitro models of drug-induced nephrotoxicity

  2018cites this paper
• Interaction of the New Monofunctional Anticancer Agent Phenanthriplatin With Transporters for Organic Cations

  2018influential citation
• Cisplatin‐induced nephrotoxicity in patients with advanced neuroblastoma

  2018cites this paper
• Human Pluripotent Stem Cell–Derived Kidney Model for Nephrotoxicity Studies

  2018cites this paper
• D-pinitol attenuates cisplatin-induced nephrotoxicity in rats: Impact on pro-inflammatory cytokines.

  2018cites this paper
• The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury

  2018cites this paper
• An approach for quantification of platinum distribution in tissues by LA-ICP-MS imaging using isotope dilution analysis.

  2018cites this paper
• Emerging Kidney Models to Investigate Metabolism, Transport, and Toxicity of Drugs and Xenobiotics

  2018cites this paper
• Early detection of acute cisplatin nephrotoxicity: interest of urinary monitoring of proximal tubular biomarkers

  2017cites this paper
• Xenobiotic transporters and kidney injury.

  2017cites this paper
• Organic cation transporter 3 mediates cisplatin and copper cross-resistance in hepatoma cells

  2017cites this paper
• Disposition and clinical implications of protein-bound uremic toxins.

  2017cites this paper
• GLOMERULAR ALTERATIONS AND DAMAGE IN THE KIDNEY

  2017cites this paper
• Two Cu(II) complexes containing 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine and amino acids: Synthesis, crystal structures, DNA/HSA binding, molecular docking, and in vitro cytotoxicity studies

  2017cites this paper
• Importance of the novel organic cation transporter 1 for tyrosine kinase inhibition by saracatinib in rheumatoid arthritis synovial fibroblasts

  2017cites this paper
• Quality Standardization and Nephroprotective Effect of Garcinia pedunculata Roxb. Fruit rind

  2017cites this paper
• Mebendazole, an antiparasitic drug, inhibits drug transporters expression in preclinical model of gastric peritoneal carcinomatosis.

  2017cites this paper
• The Role of the Kidney in Drug Elimination: Transport, Metabolism, and the Impact of Kidney Disease on Drug Clearance

  2017influential citation